Is the "Low-Hanging Fruit" Worth Picking for Antimicrobial Stewardship Programs?

被引:79
作者
Goff, Debra A. [1 ]
Bauer, Karri A. [1 ]
Reed, Erica E. [1 ]
Stevenson, Kurt B. [2 ,3 ]
Taylor, Jeremy J. [1 ]
West, Jessica E. [2 ]
机构
[1] Ohio State Wexler Univ Med Ctr, Dept Pharm, Columbus, OH 43210 USA
[2] Ohio State Univ, Div Infect Dis, Coll Med, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA
关键词
INFECTIOUS-DISEASES SPECIALIST; HEALTH-CARE EPIDEMIOLOGY; COMMUNITY HOSPITALS; ORAL ANTIBIOTICS; EARLY SWITCH; GUIDELINES; CONVERSION; PNEUMONIA; PHYSICIAN; OUTCOMES;
D O I
10.1093/cid/cis494
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A new antimicrobial stewardship program can be overwhelmed at the breadth of interventions and education required to conduct a successful program. The expression "low-hanging fruit," in reference to stewardship, refers to selecting the most obtainable targets rather than confronting more complicated management issues. These targets include intravenous-to-oral conversions, batching of intravenous antimicrobials, therapeutic substitutions, and formulary restriction. These strategies require fewer resources and less effort than other stewardship activities; however, they are applicable to a variety of healthcare settings, including limited-resource hospitals, and have demonstrated significant financial savings. Our stewardship program found that staged and systematic interventions that focus on obvious areas of need, that is, low hanging fruit, provided early successes in our expanded program with a substantial cumulative cost savings of $832 590.
引用
收藏
页码:587 / 592
页数:6
相关论文
共 30 条
  • [1] Allen LV, 2003, INT J PHARM COMPOUND, V7, P64
  • [2] [Anonymous], 2011, HEALTHC EXEC, V26, P86
  • [3] [Anonymous], 2011, HEALTHC EXEC, V26, P88
  • [4] [Anonymous], 2012, INFECT CONTROL HOSP
  • [5] [Anonymous], 2011, HEALTHC EXEC, V26, P89
  • [6] Pharmacoeconomic considerations associated with the use of intravenous-to-oral moxifloxacin for community-acquired pneumonia
    Davis, SL
    Delgado, G
    McKinnon, PS
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 : S136 - S143
  • [7] Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship
    Dellit, Timothy H.
    Owens, Robert C.
    McGowan, John E., Jr.
    Gerding, Dale N.
    Weinstein, Robert A.
    Burke, John P.
    Huskins, W. Charles
    Paterson, David L.
    Fishman, Neil O.
    Carpenter, Christopher F.
    Brennan, P. J.
    Billeter, Marianne
    Hooton, Thomas M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (02) : 159 - 177
  • [8] Projecting future drug expenditures-2011
    Doloresco, Fred
    Fominaya, Cory
    Schumock, Glen T.
    Vermeulen, Lee C.
    Matusiak, Linda
    Hunkler, Robert J.
    Shah, Nilay D.
    Hoffman, James M.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (10) : 921 - 932
  • [9] PHARMACOECONOMIC BENEFIT OF ANTIBIOTIC STEP-DOWN THERAPY - CONVERTING PATIENTS FROM INTRAVENOUS CEFTRIAXONE TO ORAL CEFPODOXIME PROXETIL
    HENDRICKSON, JR
    NORTH, DS
    [J]. ANNALS OF PHARMACOTHERAPY, 1995, 29 (06) : 561 - 565
  • [10] Rehospitalizations among Patients in the Medicare Fee-for-Service Program
    Jencks, Stephen F.
    Williams, Mark V.
    Coleman, Eric A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (14) : 1418 - 1428